论文部分内容阅读
消化性溃疡是消化科常见病,临床症状已上腹疼痛、恶心、呕吐、反胃、唾液分泌增多、嗳气等其他肠胃道症状为主。临床中主要采用H2受体拮抗剂、质子泵抑制剂、根除幽门螺杆菌(HP)感染的药物及增强胃黏膜保护作用的药物治疗消化性溃疡。然而,现如今用以治疗消化性溃疡的药物种类众多,新的药物又不断问世,如何选择,尚无统一规范。本研究通过分析消化溃疡的药物治疗现状及进展,以期为临床治疗提供参考依据。
Peptic ulcer is a common disease of the digestive system, clinical symptoms have abdominal pain, nausea, vomiting, nausea, increased salivation, belching and other gastrointestinal symptoms based. Clinical use of H2 receptor antagonists, proton pump inhibitors, eradication of Helicobacter pylori (HP) infection of drugs and enhance the protective effect of gastric mucosa drug treatment of peptic ulcer. However, there are many kinds of drugs now used to treat peptic ulcer, and new drugs are coming out. How to choose, there is no uniform norms. This study analyzed the status quo and progress of drug treatment of peptic ulcer, in order to provide a reference for clinical treatment.